CSPE NEW CE – Certificate in Specialty Pharmacy Exam Prep Course

The National Association of Specialty Pharmacy (NASP) has teamed up with ProCE to bring you the Center for Specialty Pharmacy Education (CSPE), THE official continuing education website for NASP. Most CSPE activities cover the clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. However, CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy practice.

Certificate in Specialty Pharmacy Exam Prep Course

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). The CSP Exam Preparatory Course will cover aspects of Clinical, Fulfillment, Intake and Outcomes that might be expected on the exam. Join expert faculty as key aspects of specialty pharmacy and the specialty pharmacist’s role are discussed.

The fee for this activity is $99. Earn up to a total of 6.75 contact hours for completing all modules.

Learning Objectives

 

The target audience for this activity includes pharmacists.

 

At the completion of Patient Intake, participants will be able to:

  • Outline and explain key considerations for the specialty pharmacist concerning the patient intake process.
  • Define and describe the central intake approach to the specialty pharmacy patient intake process.
  • Identify and distinguish the specific roles of pharmacists and pharmacy technicians in the patient intake process.
  • List and explain the fundamental steps of the patient intake process for specialty pharmaceuticals.
  • Identify and discuss specific business drivers as they relate to specialty pharmacy patients.
  • Compare and contrast key opportunities and challenges related to the specialty pharmacy patient intake process.

At the completion of Clinical Practice in Specialty Pharmacy, participants will be able to:

  • List the key components of the patient medical record related to the clinical management of the patient.
  • Define persistence and adherence.
  • Outline barriers to adherence.
  • Describe strategies to improve adherence.
  • Outline the various components of Risk Evaluation and Mitigation Strategies (REMS).
  • Identify the characteristics of Limited Distribution Drugs (LDD).
  • Discuss the specialty pharmacy role in assuring desired patient safety and patient outcomes.

At the completion of Clinical: Inflammatory Diseases, participants will be able to:

  • Identify different classes of medications, mechanisms of action, and indication used to treat auto-immune conditions
  • Identify standardized dosing schedules, route of administration, and storage considerations for medications used to treat auto-immune conditions
  • Discuss monitoring parameters, possible side effects, and complications associated with medications used to treat auto-immune conditions

At the completion of Clinical: Oncology, participants will be able to:

  • List dosing and indications for oral oncolytic therapies in oncology and hematology
  • Identify most commonly used therapies in practice and important counseling/monitoring parameters
  • Assess therapies for appropriateness based on drug-drug and drug-disease interactions
 

At the completion of Clinical: Hepatitis, participants will be able to:

  • Discuss the prevalence and diagnosis of hepatitis C
  • Describe the pharmacology of direct acting antivirals
  • Determine the appropriate treatment selection of a direct acting antiviral regimen
  • Identify common drug interactions with direct acting antivirals

At the completion of Clinical: Multiple Sclerosis, participants will be able to:

  • Differentiate the disease-modifying therapies (DMTs) for the treatment of multiple sclerosis (MS)
  • Identify both common and serious adverse effects, as well as significant drug/drug interactions for each DMT
  • Identify recommended monitoring parameters for each DMT, including Risk Evaluation and Mitigation Strategy (REMS) requirements
  • Recognize how each product is supplied and how to properly administer as well as store each DMT

At the completion of Fulfillment, participants will be able to:

  • Define the Pharmacist role in specialty pharmaceutical fulfillment workflows
  • Describe the steps required to screen specialty pharmacy orders
  • Explain the importance of quality assurance in the specialty product fulfillment
  • Identify primary dispensing channels
  • Compare and contrast key opportunities and challenges in the specialty pharmaceuticals fulfillment process

At the completion of Outcomes, participants will be able to:

  • Define the three categories health outcomes measures
  • Describe the value of specialty pharmacy in health outcomes terms
  • Describe outcomes that specialty pharmacies can measure to demonstrate value
  • Describe the gold standards in measuring health outcomes
  • Discuss barriers to collecting optimal health outcomes data
  • Identify how payers are managing specialty pharmaceuticals

 

Faculty

 

Erin Stack, PharmD (Patient Intake)
Supervising Pharmacist, Cottrill’s Specialty Pharmacy

King Vu, PharmD (Patient Intake)
Clinical Help Desk Pharmacist, Diplomat Pharmacy

Kevn McNamara, PharmD (Clinical)
Owner-Manager, Clinical Pharmacy Partners

April Jones, PharmD, CSP (Clinical)
Clinical Pharmacist, Specialty Pharmacy Services, Vanderbilt University Medical Center

Houston Wyatt, PharmD, CSP (Clinical)
Clinical Pharmacist, Specialty Pharmacy Services, Vanderbilt University Medical Center

 

Alicia Carver, PharmD, BCPS, CSP (Clinical)
Clinical Pharmacist, Specialty Pharmacy Services, Vanderbilt University Medical Center

Aimee Banks, PharmD, BCPS (Clinical)
Clinical Pharmacist, Multiple Sclerosis Clinic, Vanderbilt University Medical Center

Stephen Lagano, MS, PE (Fulfillment)
CEO, Altometrixs

Kanika Kapoor, PharmD, CSP (Outcomes)
Clinical Pharmacist, Diplomat Pharmacy

 

Accreditation

Pharmacists

ACPE LogoThis CE activity is jointly provided by ProCE, Inc. and NASP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Numbers 0221-9999-17-061-H04-P, 0221-9999-17-062-H01-P, 0221-9999-17-063-H01-P, 0221-9999-17-064-H01-P, 0221-9999-17-065-H01-P, 0221-9999-17-066-H01-P, 0221-9999-17-067-H04-P, and 0221-9999-17-068-H04-P have been assigned to these knowledge-based home-study CE activities (initial release date 02-06-17). These activities (8 individual activities) are approved for a maximum of 6.75 total contact hours (0.675 CEU) in states that recognize ACPE providers. Completion of the evaluations and the post-tests with a score of 70% or higher are required to receive CE credit. No partial credit will be given.

Top